These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 687752)
1. Preliminary results of the combination methotrexate-asparaginase in patients with acute non lymphoid leukemia. Mandelli F; Amadori S; Pacilli L; Tribalto M Biomedicine; 1978 Jun; 29(4):116-7. PubMed ID: 687752 [TBL] [Abstract][Full Text] [Related]
2. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia. Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851 [TBL] [Abstract][Full Text] [Related]
3. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults. Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ Cancer Treat Rep; 1981; 65 Suppl 1():83-7. PubMed ID: 6948610 [TBL] [Abstract][Full Text] [Related]
4. Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer. Yap HY; Benjamin RS; Blumenschein GR; Hortobagyi GN; Tashima CK; Buzdar AU; Bodey GP Cancer Treat Rep; 1979 Jan; 63(1):77-83. PubMed ID: 369695 [TBL] [Abstract][Full Text] [Related]
5. Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells. Capizzi RL Cancer Treat Rep; 1981; 65 Suppl 4():115-21. PubMed ID: 7049375 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate plus L-asparaginase. An active combination for children with acute nonlymphocytic leukemia. Hudson MM; Dahl GV; Kalwinsky DK; Pui CH Cancer; 1990 Jun; 65(12):2615-8. PubMed ID: 2340462 [TBL] [Abstract][Full Text] [Related]
7. [Attempts at treatment of acute leukemia with L-asparaginase]. Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225 [No Abstract] [Full Text] [Related]
8. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020 [TBL] [Abstract][Full Text] [Related]
9. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen. Bassan R; Battista R; Viero P; Pogliani E; Rossi G; Lambertenghi-Deliliers G; Rambaldi A; D'Emilio A; Buelli M; Borleri G Semin Oncol; 1993 Dec; 20(6 Suppl 8):39-46. PubMed ID: 7507263 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia. Tribalto M; Amadori S; Avvisati G; Del Bianco P; Franchi A; Gallerano T; Papa G; Mandelli F Haematologica; 1985; 70(4):319-23. PubMed ID: 3935530 [No Abstract] [Full Text] [Related]
11. [Experience in the therapy of acute leukemia in the period from March, 1959 to February, 1971]. Quattrin N; Montuori R Minerva Med; 1972 Mar; 63(24):1409-22. PubMed ID: 4502503 [No Abstract] [Full Text] [Related]
12. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate. Yap BS; McCredie KB; Benjamin RS; Bodey GP; Freireich EJ Br Med J; 1978 Sep; 2(6140):791-3. PubMed ID: 279387 [TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study. Lange BJ; Blatt J; Sather HN; Meadows AT Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy]. Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118 [TBL] [Abstract][Full Text] [Related]
17. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607 [TBL] [Abstract][Full Text] [Related]
18. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of 2 regimens of polychemotherapy in refractory acute leukemia or in relapse]. Borbolla-Escoboza JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba-Christy E; Anaya-Cuéllar I Rev Invest Clin; 1998; 50(4):307-10. PubMed ID: 9830318 [TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Refsum H; Wesenberg F; Ueland PM Cancer Res; 1991 Feb; 51(3):828-35. PubMed ID: 1988122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]